葛兰素史克(GSK.US)1类新药德莫奇单抗又一项新适应症上市申请获得受理
葛兰素史克(GSK.US)超长效IL-5单抗率先在华申报上市
欧洲医疗保健股前景复杂 美国政策及新药试验结果成关键
India Drug Delivery Devices Market 2024, With Profiles of Pfizer, Novartis, GlaxoSmithKline, India Medtronic, Cardinal Health, B. Braun Medical, Sun Pharmaceutical, 3M, Cipla & Bayer Zydus Pharma
葛兰素史克(GSK.US)药物在多发性骨髓瘤研究中将死亡风险降低 42%
Kaposi Sarcoma Strategic Market Research Report 2024-2030, Competitor Profiles of 14 Players Including Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer - ResearchAndMarkets.com
葛兰素史克(GSK.US)IBAT抑制剂治疗PBC相关胆汁淤积性瘙痒III期研究成功
葛兰素史克(GSK.US)抗癌药物Blenrep显著降低死亡风险 有望重获监管批准
FDA建议停止使用感冒药中常见减充血剂 葛兰素史克(GSK.US)等公司或受影响
Dermatology Treatment and Care Market Research 2024-2030 Featuring Novartis, Pfizer, Amgen, GlaxoSmithKline, F. Hoffmann-La Roche, Johnson & Johnson, AbbVie, Merck & Co, Bayer, and Sanofi - ResearchAndMarkets.com
葛兰素史克(GSK.US)Q3利润超预期 畅销疫苗销量暴跌成隐患
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q2 2024 Earnings Call Highlights: Revenue ...
GSK再度来华收购创新药!签下8.5亿美元协议 拓展红斑狼疮管线
葛兰素史克(GSK.US)实验性药物Depemokimab治疗鼻炎试验取得积极结果
葛兰素史克(GSK.US)同意支付22亿美元以解决约8万起胃灼热药物Zantac有关诉讼
RSV疫苗在美销量大降 “最有想象力产品”遭CDC重击
葛兰素史克(GSK.US)称RSV疫苗保护作用可持续三个季度
Alembic Pharmaceuticals Gets US FDA Final Nod for Lamotrigine Extended-Release Tablets
杰富瑞:将葛兰素史克目标价下调至53美元
美股收盘:议息夜过山车走势令人心惊 三大指数小幅收跌
データなし